Individualized indication for neoadjuvant treatment based on metabolic response assessed by 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in adenocarcinoma of the esophago-gastric junction (AEG). - Lordick,F.; Ott,K.; Weber,W.A.; Stein,H.J.; Becker,K.; Wieder,H.; Roethling,N.; Hennig,M.; Peschel,C.; Schwaiger,M.; Siewert,J.R. (Journal of Clinical Oncology, 2005)